Merges, Acquisitions & Asset Sales
...
...
...
...
...
...
...
...
Recent case shows why failing to disclose to individuals the lab test list prices they may need to pay doesn’t count as consumer fraud.
Learn how your lab can effectively respond in these uncertain economic times to strengthen your competitive advantage and your bottom line.
The acquisition of the Johns Hopkins spin out and its liquid biopsy ctDNA test will significantly strengthen Quest’s oncology offerings.